Regarding mechanism, MFAP2 was mainly involved in ATP formation; TP53 mutation interacted with MFAP2 to participate in the hepatocellular carcinoma cell occurrence, and MFAP2 knockdown inhibited hepatocellular carcinoma cell proliferation (21). The gene discussed is MFAP2; the disease is hepatocellular carcinoma.